![Håkan Rosén](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Håkan Rosén
Director/Board Member at Glucox Biotech AB
Net worth: 704 307 $ as of 2024-05-30
Profile
Håkan Rosén is Head of SAAB Ventures and Investment Manager of Iteksa Venture AB.
He is a Director of Micromuscle AB.
He received an MS degree from Linköpings Universitet.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
FORTNOX AB
0.02% | 2024-05-01 | 114,205 ( 0.02% ) | 704 307 $ | 2024-05-30 |
Håkan Rosén active positions
Companies | Position | Start |
---|---|---|
Glucox Biotech AB
![]() Glucox Biotech AB Pharmaceuticals: MajorHealth Technology Glucox Biotech AB is a holding company. It develops clinically applicable therapeutics for treatment of type 2 diabetes; hyperglycaemia, insulin resistance and resulting complications. The firm explores new ideas for the prevention of cellular damage in ischemic stroke and heart infarction, as well the idea behind Glucox Biotech's therapies is to reduce oxidative stress by preventing the intracellular formation of reactive oxygen species. The company was founded by Ellen Mona Gratia Wilcke and Per Ingvar O. Wikström on July 1, 2003 and is headquartered in Stockholm, Sweden. | Director/Board Member | - |
Former positions of Håkan Rosén
Companies | Position | End |
---|---|---|
Saab Ventures AB
![]() Saab Ventures AB Investment ManagersFinance Saab Ventures is the venture capital unit of Saab AB (ST: SAAB), which was founded in 1937 as Svenska Aeroplan Aktiebolaget to produce military aircraft for Sweden. Grown into a global group, the firm provides products and services for military defense and civil security. Their corporate venture division Saab Ventures was established in 2001 and is based in Linköping, Sweden. Saab Ventures invests from the balance sheet of Saab and focuses on technologies and markets that are relevant to Saab's short- and long-term strategies. They aim to enhance Saab's access to innovative key technologies. | Chief Investment Officer | 2008-12-30 |
Svenska TRACAB AB
![]() Svenska TRACAB AB Packaged SoftwareTechnology Services TRACAB is the world leading company in creating real-time digital sports data and in turn converting the data into powerful content products for sports fans. Using patented image processing technology developed by its shareholder SAAB, TRACAB is able to capture all movements in a sports arena in real-time. The captured data is packaged into different media products for different platforms such as broadband, broadcast, print and mobile. It is made available to the consumer both in real-time and in post-production. The technology is well proven and is used by several national football leagues and the UEFA Champions League. It was also used for all matches during the EURO 2008. Since 2004, the TRACAB system has been used in over 1,000 live matches. | Director/Board Member | - |
Micromuscle AB
![]() Micromuscle AB Medical SpecialtiesHealth Technology Micromuscle AB develops electro-active polymer technology products. It focuses on vascular applications where EAP has considerable potential and enables functionality for medical devices. The company's products are used in medical and life science applications. Micromuscle was founded in 2000 and is headquartered in Linköping, Sweden | Director/Board Member | - |
Iteksa Venture AB
![]() Iteksa Venture AB Investment ManagersFinance Iteksa Venture AB is engaged in developing the companies in its portfolio and making investments in new companies. It invests primarily in high-tech companies in the Linköping region. The company is headquartered in Linköping, Sweden. | Director/Board Member | - |
Training of Håkan Rosén
University of Linköping | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 5 |
---|---|
Micromuscle AB
![]() Micromuscle AB Medical SpecialtiesHealth Technology Micromuscle AB develops electro-active polymer technology products. It focuses on vascular applications where EAP has considerable potential and enables functionality for medical devices. The company's products are used in medical and life science applications. Micromuscle was founded in 2000 and is headquartered in Linköping, Sweden | Health Technology |
Iteksa Venture AB
![]() Iteksa Venture AB Investment ManagersFinance Iteksa Venture AB is engaged in developing the companies in its portfolio and making investments in new companies. It invests primarily in high-tech companies in the Linköping region. The company is headquartered in Linköping, Sweden. | Finance |
Saab Ventures AB
![]() Saab Ventures AB Investment ManagersFinance Saab Ventures is the venture capital unit of Saab AB (ST: SAAB), which was founded in 1937 as Svenska Aeroplan Aktiebolaget to produce military aircraft for Sweden. Grown into a global group, the firm provides products and services for military defense and civil security. Their corporate venture division Saab Ventures was established in 2001 and is based in Linköping, Sweden. Saab Ventures invests from the balance sheet of Saab and focuses on technologies and markets that are relevant to Saab's short- and long-term strategies. They aim to enhance Saab's access to innovative key technologies. | Finance |
Svenska TRACAB AB
![]() Svenska TRACAB AB Packaged SoftwareTechnology Services TRACAB is the world leading company in creating real-time digital sports data and in turn converting the data into powerful content products for sports fans. Using patented image processing technology developed by its shareholder SAAB, TRACAB is able to capture all movements in a sports arena in real-time. The captured data is packaged into different media products for different platforms such as broadband, broadcast, print and mobile. It is made available to the consumer both in real-time and in post-production. The technology is well proven and is used by several national football leagues and the UEFA Champions League. It was also used for all matches during the EURO 2008. Since 2004, the TRACAB system has been used in over 1,000 live matches. | Technology Services |
Glucox Biotech AB
![]() Glucox Biotech AB Pharmaceuticals: MajorHealth Technology Glucox Biotech AB is a holding company. It develops clinically applicable therapeutics for treatment of type 2 diabetes; hyperglycaemia, insulin resistance and resulting complications. The firm explores new ideas for the prevention of cellular damage in ischemic stroke and heart infarction, as well the idea behind Glucox Biotech's therapies is to reduce oxidative stress by preventing the intracellular formation of reactive oxygen species. The company was founded by Ellen Mona Gratia Wilcke and Per Ingvar O. Wikström on July 1, 2003 and is headquartered in Stockholm, Sweden. | Health Technology |
- Stock Market
- Insiders
- Håkan Rosén